This article is a correction to:
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
Bram Decru1†
Jan Van Elslande1†
Sophie Steels1
Gijs Van Pottelbergh2,3
Lode Godderis2,3,4,5Bram Van Holm6
Xavier Bossuyt1
Johan Van Weyenbergh6‡
Piet Maes6‡
Pieter Vermeersch1,7*‡- 1University Hospitals Leuven, Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, Leuven, Belgium
- 2Academic Centre of General Practice, KU Leuven, Leuven, Belgium
- 3Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
- 4Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
- 5Group IDEWE, External Service for Prevention and Protection at Work, Heverlee, Belgium
- 6Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium
- 7Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium
by Decru B, Van Elslande J, Steels S, Van Pottelbergh G, Godderis L, Van Holm B, Bossuyt X, Van Weyenbergh J, Maes P and Vermeersch P (2022) Front. Immunol. 13:909910. doi: 10.3389/fimmu.2022.909910
In the published article, there was an error regarding the equal contributions for Bram Decru and Jan Van Elslande. These authors have contributed equally to this work and share first authorship.
Bram Decru1†, Jan Van Elslande1†, Sophie Steels1, Gijs Van Pottelbergh2,3, Lode Godderis2,3,4,5, Bram Van Holm6, Xavier Bossuyt1, Johan Van Weyenbergh6‡, Piet Maes6‡ and Pieter Vermeersch1,7*‡
†These authors contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share senior authorship
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, COVD-19 serological testing, neutralizing antibodies, vaccination, spike, IgG, immunity, COVID-19
Citation: Decru B, Van Elslande J, Steels S, Van Pottelbergh G, Godderis L, Van Holm B, Bossuyt X, Van Weyenbergh J, Maes P and Vermeersch P (2022) Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers. Front. Immunol. 13:1098285. doi: 10.3389/fimmu.2022.1098285
Received: 14 November 2022; Accepted: 15 November 2022;
Published: 25 November 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Decru, Van Elslande, Steels, Van Pottelbergh, Godderis, Van Holm, Bossuyt, Van Weyenbergh, Maes and Vermeersch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pieter Vermeersch, pieter.vermeersch@uzleuven.be
†These authors contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share senior authorship